Attenuation of toll-like receptor expression and function in latent tuberculosis by coexistent filarial infection with restoration following antifilarial chemotherapy.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMC 2710006)

Published in PLoS Negl Trop Dis on July 28, 2009

Authors

Subash Babu1, Sajid Q Bhat, N Pavan Kumar, R Anuradha, Paul Kumaran, P G Gopi, C Kolappan, V Kumaraswami, Thomas B Nutman

Author Affiliations

1: National Institutes of Health-International Center for Excellence in Research, Chennai, India. sbabu@mail.nih.gov

Articles citing this

Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol (2013) 1.55

Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle. Nat Commun (2012) 1.20

TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am J Pathol (2010) 1.06

Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS (2012) 1.05

Genetic determinants of immune-response to a polysaccharide vaccine for typhoid. Hugo J (2010) 1.04

Modulation of specific and allergy-related immune responses by helminths. J Biomed Biotechnol (2011) 0.98

Helminth infection impairs autophagy-mediated killing of bacterial enteropathogens by macrophages. J Immunol (2012) 0.97

Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection. PLoS Negl Trop Dis (2012) 0.95

Modulation of mycobacterial-specific Th1 and Th17 cells in latent tuberculosis by coincident hookworm infection. J Immunol (2013) 0.93

Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis. Parasitol Res (2010) 0.88

Enhanced pro-inflammatory cytokine responses following Toll-like-receptor ligation in Schistosoma haematobium-infected schoolchildren from rural Gabon. PLoS One (2011) 0.87

Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen-driven IL-12 and IFN-γ in filaria-malaria co-infection. Eur J Immunol (2012) 0.84

Helminth-induced immune regulation: implications for immune responses to tuberculosis. PLoS Pathog (2015) 0.83

Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? Pathog Dis (2013) 0.81

Regulation of global gene expression in human Loa loa infection is a function of chronicity. PLoS Negl Trop Dis (2012) 0.77

Genomics of immune response to typhoid and cholera vaccines. Philos Trans R Soc Lond B Biol Sci (2015) 0.77

Helminth-Tuberculosis Co-infection: An Immunologic Perspective. Trends Immunol (2016) 0.77

Immunological mechanisms by which concomitant helminth infections predispose to the development of human tuberculosis. Korean J Parasitol (2012) 0.77

Anthelmintic Therapy Modifies the Systemic and Mycobacterial Antigen-Stimulated Cytokine Profile in Helminth-Latent Mycobacterium tuberculosis Coinfection. Infect Immun (2017) 0.75

Stat6-Dependent Inhibition of Mincle Expression in Mouse and Human Antigen-Presenting Cells by the Th2 Cytokine IL-4. Front Immunol (2016) 0.75

Articles cited by this

Toll-like receptors. Annu Rev Immunol (2001) 26.06

Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91

Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell (2004) 12.71

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08

Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol (2003) 5.97

Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87

TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med (2005) 3.44

IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J Immunol (2007) 2.73

IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol (1999) 2.69

Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest (2004) 2.65

Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine (2008) 2.37

Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology (2007) 2.37

The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev (2008) 2.36

Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev (2000) 2.29

Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol (2004) 2.27

Toll-like receptors and their ligands. Curr Top Microbiol Immunol (2002) 2.02

Innate immunity in tuberculosis: myths and truth. Microbes Infect (2008) 2.00

Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol (2003) 2.00

MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun (2004) 1.89

Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol (2005) 1.64

Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. Eur J Immunol (2008) 1.59

Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J Immunol (2006) 1.52

Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis (2009) 1.43

Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol (2005) 1.31

Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis (2005) 1.31

Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis (2004) 1.21

Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF. Ann Rheum Dis (2003) 1.14

TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol (2007) 1.13

Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int J Tuberc Lung Dis (2003) 1.07

Activation and regulation of toll-like receptors (TLRs) by helminth parasites. Immunol Res (2009) 1.07

Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect Immun (2004) 1.06

Inhibition of Toll Like Receptor immune responses by microbial pathogens. Front Biosci (2005) 0.95

Toll-like receptors and control of mycobacterial infection in mice. Novartis Found Symp (2006) 0.79

Articles by these authors

Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev (2004) 5.41

Draft genome of the filarial nematode parasite Brugia malayi. Science (2007) 5.28

Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (2002) 3.89

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med (1997) 3.53

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04

A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65

Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65

Gender disparities in tuberculosis: report from a rural DOTS programme in south India. Int J Tuberc Lung Dis (2004) 2.64

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood (2003) 2.61

Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis (2008) 2.55

Rapid decline in prevalence of pulmonary tuberculosis after DOTS implementation in a rural area of South India. Int J Tuberc Lung Dis (2008) 2.43

Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis (2005) 2.41

Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence. J Immunol (2006) 2.29

Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador. Am J Respir Crit Care Med (2003) 2.28

Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels. Clin Infect Dis (2010) 2.23

A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med (2009) 2.21

The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 2.13

A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. N Engl J Med (1990) 2.11

Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00

Health-seeking behaviour of new smear-positive TB patients under a DOTS programme in Tamil Nadu, India, 2003. Int J Tuberc Lung Dis (2007) 1.99

Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. J Invest Dermatol (2004) 1.98

Tobacco smoking and pulmonary tuberculosis. Thorax (2002) 1.96

A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis (2009) 1.89

Brugia malayi excreted/secreted proteins at the host/parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis (2009) 1.88

Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis (2009) 1.82

Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis (2006) 1.79

Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol (2001) 1.78

Isolation of tubercle bacilli from sputum samples of patients in the field studies by the cetylpyridinium chloride-sodium chloride & sodium hydroxide methods. Indian J Med Res (1995) 1.71

IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol (1981) 1.71

Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol (2010) 1.70

Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol (2003) 1.65

Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection. J Clin Microbiol (2008) 1.65

Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis (2008) 1.63

Molecular mimicry between cockroach and helminth glutathione S-transferases promotes cross-reactivity and cross-sensitization. J Allergy Clin Immunol (2012) 1.58

Genomics of Loa loa, a Wolbachia-free filarial parasite of humans. Nat Genet (2013) 1.52

Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J Immunol (2006) 1.52

High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51

Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis (2012) 1.50

Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis (2006) 1.48

Nodding syndrome. Emerg Infect Dis (2013) 1.45

Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun (2004) 1.43

Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis (2009) 1.43

Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti. PLoS Negl Trop Dis (2012) 1.42

At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J Immunol (2010) 1.42

A novel method of staining acid-fast bacilli in sputum containers. Indian J Med Res (2006) 1.39

IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood (2003) 1.37

Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis (2002) 1.36

An Epidemiologic Investigation of Potential Risk Factors for Nodding Syndrome in Kitgum District, Uganda. PLoS One (2013) 1.36

Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis (2013) 1.36

Status of re-registered patients for tuberculosis treatment under DOTS programme. Indian J Tuberc (2007) 1.34

KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol (2007) 1.33

Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun (2001) 1.32

Parasite antigen-driven basophils are a major source of IL-4 in human filarial infections. J Immunol (2004) 1.32

Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol (2005) 1.31

Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in Brugian filariasis. Trop Med Int Health (2002) 1.30

Filarial lymphedema is characterized by antigen-specific Th1 and th17 proinflammatory responses and a lack of regulatory T cells. PLoS Negl Trop Dis (2009) 1.30

Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest (1987) 1.28

Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India. Indian J Tuberc (2008) 1.28

Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood (2008) 1.27

Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis (2007) 1.27

Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis (2011) 1.26

Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients. Int J Tuberc Lung Dis (2007) 1.26

Filariasis in travelers presenting to the GeoSentinel Surveillance Network. PLoS Negl Trop Dis (2007) 1.26

Prenatal allergic sensitization to helminth antigens in offspring of parasite-infected mothers. J Clin Invest (1983) 1.25

The prevalence of tuberculosis in different economic strata: a community survey from South India. Int J Tuberc Lung Dis (2007) 1.25

Are community surveys to detect tuberculosis in high prevalence areas useful? Results of a comparative study from Tiruvallur District, South India. Int J Tuberc Lung Dis (2003) 1.25

Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun (2004) 1.24

Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24

Identification of Wb123 as an early and specific marker of Wuchereria bancrofti infection. PLoS Negl Trop Dis (2012) 1.23

A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Public Health (1995) 1.23

Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood (2003) 1.21

Lymphatics in human lymphatic filariasis: in vitro models of parasite-induced lymphatic remodeling. Lymphat Res Biol (2009) 1.21

Class and subclass selection in parasite-specific antibody responses. Trends Parasitol (2003) 1.21

Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population. J Immunol (2009) 1.21

A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi infection. Trans R Soc Trop Med Hyg (2001) 1.20

Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci U S A (2011) 1.20

Comparative genomics of gene expression in the parasitic and free-living nematodes Strongyloides stercoralis and Caenorhabditis elegans. Genome Res (2004) 1.20

Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol (2003) 1.19

Immunopathogenesis of lymphatic filarial disease. Semin Immunopathol (2012) 1.19

Tuberculosis situation among tribal population of Car Nicobar, India, 15 years after intensive tuberculosis control project and implementation of a national tuberculosis programme. Bull World Health Organ (2004) 1.19

A novel, multi-parallel, real-time polymerase chain reaction approach for eight gastrointestinal parasites provides improved diagnostic capabilities to resource-limited at-risk populations. Am J Trop Med Hyg (2013) 1.19